A new trading day began on Friday, with Fulgent Genetics Inc (NASDAQ: FLGT) stock price up 18.15% from the previous day of trading, before settling in for the closing price of $22.31. FLGT’s price has ranged from $14.57 to $24.64 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -129.89%. Meanwhile, its annual earnings per share averaged -38.83%. With a float of $19.75 million, this company’s outstanding shares have now reached $30.85 million.
Fulgent Genetics Inc (FLGT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Fulgent Genetics Inc is 35.47%, while institutional ownership is 55.24%. The most recent insider transaction that took place on Sep 03 ’25, was worth 23,414. In this transaction Chief Scientific Officer of this company sold 1,063 shares at a rate of $22.03, taking the stock ownership to the 957,085 shares. Before that another transaction happened on Sep 03 ’25, when Company’s President and COO sold 1,128 for $22.03, making the entire transaction worth $24,846. This insider now owns 364,121 shares in total.
Fulgent Genetics Inc (FLGT) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
Fulgent Genetics Inc (NASDAQ: FLGT) Trading Performance Indicators
Here are Fulgent Genetics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.40, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Fulgent Genetics Inc (FLGT)
The latest stats from [Fulgent Genetics Inc, FLGT] show that its last 5-days average volume of 0.36 million was superior to 0.32 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 45.46%.
During the past 100 days, Fulgent Genetics Inc’s (FLGT) raw stochastic average was set at 90.37%, which indicates a significant increase from 81.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.91 in the past 14 days, which was higher than the 0.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.68, while its 200-day Moving Average is $19.72. Now, the first resistance to watch is $27.92. This is followed by the second major resistance level at $29.48. The third major resistance level sits at $31.60. If the price goes on to break the first support level at $24.24, it is likely to go to the next support level at $22.12. The third support level lies at $20.56 if the price breaches the second support level.
Fulgent Genetics Inc (NASDAQ: FLGT) Key Stats
With a market capitalization of 806.85 million, the company has a total of 30,609K Shares Outstanding. Currently, annual sales are 283,470 K while annual income is -42,710 K. The company’s previous quarter sales were 81,800 K while its latest quarter income was -18,960 K.
